EVALUATION OF THE ABSORB EVEROLIMUS ELUTING BIORESORBABLE VASCULAR SCAFFOLD (ABSORB BVS) IN THE TREATMENT OF PATIENTS WITH DE NOVO NATIVE CORONARY ARTERY LESIONS: 2 YEAR CLINICAL RESULTS OF ABSORB COHORT B TRIAL
2012 ◽
Vol 59
(13)
◽
pp. E319
◽
2012 ◽
Vol 60
(17)
◽
pp. B11
◽
2018 ◽
Vol 72
(13)
◽
pp. B128-B129
2019 ◽
Vol 74
(13)
◽
pp. B164
2013 ◽
Vol 62
(18)
◽
pp. B11
◽
2014 ◽
Vol 63
(12)
◽
pp. A1706
◽
2013 ◽
Vol 61
(10)
◽
pp. E1731
◽
2017 ◽
Vol 69
(16)
◽
pp. S2